Senior Product Manager (Japanese Bilingual Preferred) at Click Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Digital Therapeutics, HealthcareIndustries

Requirements

Japanese Bilingual Preferred
Ability to work hybrid (3+ days in office per week in Tribeca, NYC)
Confidence in understanding user needs and transforming them into engaging solutions
Experience collaborating with clinicians, scientists, product designers, software engineers, market researchers, and data scientists
Focus/experience delivering products through clinical trials and to market

Responsibilities

Work in collaboration with scientific, business, and engineering leaders to rapidly define and develop features that deliver therapeutic value to our patients & our partners
Understand scientific concepts and identify opportunities to translate ideas into testable, scalable products and prototypes
Deeply understand and synthesize the complexities of the healthcare environment including regulations, existing clinical workflows, and patient journeys into high potential product opportunities
Facilitate workshops with external business partners to gather requirements, drive consensus, and clarify strategic direction
Translate requirements into

Skills

Product Management

User Needs Analysis

User-Centered Design

Digital Therapeutics

Healthcare Software

Clinician Collaboration

Scientist Collaboration

Cross-Functional Collaboration

Japanese Bilingual

Click Therapeutics

Develops software as prescription medical treatments

About Click Therapeutics

Click Therapeutics develops software applications that function as prescription medical treatments for patients with various health conditions. These digital therapeutics are designed to change cognitive and neurobehavioral mechanisms related to diseases, and they are tested through rigorous randomized controlled trials to ensure safety and effectiveness. After validation, the company seeks FDA clearance to market these applications as class II medical devices. Unlike traditional pharmaceuticals, Click Therapeutics' products are prescribed by physicians and reimbursed by payers, allowing for a unique revenue model. A notable collaboration with Boehringer Ingelheim aims to create a digital therapeutic for schizophrenia, highlighting the potential of this approach in healthcare. The goal of Click Therapeutics is to provide effective digital solutions for patients with unmet medical needs, continuously improving their applications using real-world evidence.

New York City, New YorkHeadquarters

2012Year Founded

$93.9MTotal Funding

DEBTCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Unlimited Paid Time Off

Flexible Work Arrangement

Stock Options

Performance Bonus

Fertility Treatment Support

Professional Development Budget

Commuter Benefits

Risks

Increased competition from digital therapeutic companies may impact market share.

Regulatory changes could affect approval processes for new digital therapeutics.

Integration challenges from acquisitions may delay new product development.

Differentiation

Click Therapeutics specializes in software as medical treatments for unmet medical needs.

Their Clickometrics® platform personalizes user experience to optimize engagement and outcomes.

Partnership with Boehringer Ingelheim highlights their collaborative approach in digital therapeutics.

Upsides

FDA clearance of Rejoyn™ boosts credibility in digital therapeutics for mental health.

Acquisition of Better Therapeutics expands Click's reach into cardiometabolic diseases.

$20 million financing from HSBC supports expansion and development initiatives.

Land your dream remote job 3x faster with AI

Try Jobo Free